Trial Profile
Relative Bioavailability Study Between the Formulations: Paroxetine 25 mg Tablet With Controlled Release Manufactured by GSK Mississauga and Paroxetine 25 mg Tablets With Controlled Release Manufactured by SmithKline Beecham (Cidra), Fasted Administration in Healthy Volunteers for Both Genders.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary)
- Indications Depressive disorders
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 23 Mar 2011 New trial record